| Revenue | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 |
| Total Revenue | 170,756,000 | 160,546,000 | 163,786,000 | 146,801,000 |
| Cost of Revenue | 79,419,000 | 77,810,000 | 77,190,000 | 67,046,000 |
| Gross Profit | 91,337,000 | 82,736,000 | 86,596,000 | 79,755,000 |
| Operating Expenses |
| Research Development | - | - | - | - |
| Selling General and Administrative | 31,289,000 | 34,354,000 | 35,844,000 | 32,544,000 |
| Non Recurring | - | - | - | - |
| Others | - | - | - | - |
| Total Operating Expenses | 139,138,000 | 136,551,000 | 138,881,000 | 121,606,000 |
| Operating Income or Loss | 31,618,000 | 23,995,000 | 24,905,000 | 25,195,000 |
| Income from Continuing Operations |
| Total Other Income/Expenses Net | -6,745,000 | -8,856,000 | -5,093,000 | -4,503,000 |
| Earnings Before Interest and Taxes | 31,618,000 | 23,995,000 | 24,905,000 | 25,195,000 |
| Interest Expense | -7,957,000 | -6,300,000 | -4,910,000 | -4,120,000 |
| Income Before Tax | 24,873,000 | 15,139,000 | 19,812,000 | 20,692,000 |
| Income Tax Expense | 4,920,000 | -14,708,000 | 6,479,000 | 7,005,000 |
| Minority Interest | 9,795,000 | 1,146,000 | 975,000 | 969,000 |
| Net Income From Continuing Ops | 19,953,000 | 29,847,000 | 13,333,000 | 13,687,000 |
| Non-recurring Events |
| Discontinued Operations | - | - | - | - |
| Extraordinary Items | - | - | - | - |
| Effect Of Accounting Changes | - | - | - | - |
| Other Items | - | - | - | - |
| Net Income |
| Net Income | 19,370,000 | 29,450,000 | 12,976,000 | 13,345,000 |
| Preferred Stock And Other Adjustments | - | - | - | - |
| Net Income Applicable To Common Shares | 19,370,000 | 29,450,000 | 12,976,000 | 13,345,000 |